Humacyte (HUMA) Change in Cash (2020 - 2026)
Humacyte (HUMA) posted quarterly Change in Cash of -$2.0 million for Q1 2026, down 110.93% year-over-year from $17.9 million in Q1 2025, and down 106.31% quarter-over-quarter from $31.0 million in Q4 2025.
Humacyte (HUMA) Change in Cash (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has reported Change in Cash for 7 consecutive years, with -$2.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 110.93% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$64.3 million (down 2319.41% YoY), while the FY2025 annual figure was -$44.4 million, down 406.72% from the prior year.
- Change in Cash fell to -$2.0 million in Q1 2026 per HUMA's latest filing, from $31.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $35.1 million in Q1 2024 and bottomed at -$68.5 million in Q3 2025.
- Historically, Change in Cash has averaged -$9.9 million across 5 years, with a median of -$17.2 million in 2022.
- Annual changes were most pronounced in 2022 — Change in Cash slumped 510.3% — and 2024, when it jumped 273.53%.
- Humacyte's Change in Cash stood at -$14.0 million in 2022, then plunged by 39.97% to -$19.5 million in 2023, then surged by 224.7% to $24.4 million in 2024, then gained by 27.26% to $31.0 million in 2025, then slumped by 106.31% to -$2.0 million in 2026.
- Business Quant data shows HUMA's Change in Cash at -$2.0 million in Q1 2026, $31.0 million in Q4 2025, and -$68.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Humacyte | 150.77 Mn | 150.77 Mn | -825,000.00 | 31.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.36 Mn |
| Mar 31, 2026 | -1.96 Mn |
| Dec 31, 2025 | 31.01 Mn |
| Sep 30, 2025 | -68.54 Mn |
| Jun 30, 2025 | -24.82 Mn |
| Mar 31, 2025 | 17.91 Mn |
| Dec 31, 2024 | 24.37 Mn |
| Sep 30, 2024 | -22.99 Mn |
| Jun 30, 2024 | -21.94 Mn |
| Mar 31, 2024 | 35.06 Mn |
| Dec 31, 2023 | -19.54 Mn |
| Sep 30, 2023 | -14.26 Mn |
| Jun 30, 2023 | -14.97 Mn |
| Mar 31, 2023 | -20.20 Mn |
| Dec 31, 2022 | -13.96 Mn |
| Sep 30, 2022 | -17.30 Mn |
| Jun 30, 2022 | -17.19 Mn |
| Mar 31, 2022 | -19.28 Mn |
| Dec 31, 2021 | -22.95 Mn |
| Sep 30, 2021 | 211.48 Mn |